| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| O795393 | MACKLIN | 奥氮平 | 10mM in DMSO | 434元/1ml; | 展开 |
|
| O0393 | TCI | Olanzapine | >98.0%(GC)(T) | 870元/1G; 2190元/5G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(GC)(T) | | 分子式/分子量 | C17H20N4S = 312.44 | | 外观与形状(20℃) | 固体 | | 储存温度 | 0-10℃ | | 应避免的情况 | 加热 | | Reaxys-RN | 7655141 | | PubChem物质ID | 160871343 | | Merck Index (14) | 6822 | | MDL编号 | MFCD00866702 |
技术规格 | Appearance | Light yellow to Amber to Dark green powder to crystal | | Purity(GC) | min. 98.0 % | | Purity(Nonaqueous Titration) | min. 98.0 % |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。
H315 : 造成皮肤刺激。
H319 : 造成严重眼刺激。
H413 : 可能对水生生物造成长期持续有害影响。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。
P273 : 避免释放到环境中。
P270 : 使用本产品时不要进食、饮水或吸烟。
P264 : 作业后彻底清洗皮肤。
P280 : 戴防护手套/戴防护眼罩/戴防护面具。
P302 + P352 : 如皮肤沾染：用水充分清洗。
P337 + P313 : 如仍觉眼刺激：求医/就诊。
P305 + P351 + P338 : 如进入眼睛：用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出，取出隐形眼镜。继续冲洗。
P362+P364 : 脱掉沾污的衣服，清洗后方可重新使用。
P332 + P313 : 如发生皮肤刺激：求医/就诊。
P301 + P310 + P330 : 如误吞咽：立即呼叫急救中心/医生。漱口。
P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| C46429 | Alfa Aesar | Olanzapine | | 2629元/1g; 8584元/5g; | 展开 |
基本信息 Ref#
46429 分子式
C17H20N4S 分子量
84.18 GHS危害和防范说明 GHS符号
Hazard Statements
H301 H315 H319 Precautionary Statements
P301+P310 P302+P352 P332+P313 P337+P313 P280 安全信息 危险等级
6.1 |
| PHR1825 | Supelco | Olanzapine | Pharmaceutical Secondary Standard; Certified Reference Material | 2999.3元/1 G; | 展开 |
产品说明 一般描述 质量控制用药物二级标准品，为制药行业实验室及生产商制备内部工作标准品，提供了一种方便、高性价比的替代方案。奥氮平是一种典型的抗精神病药物，被广泛应用于急性精神分裂和精神病的治疗。 应用 这些二级标准品是合格的认证标准物质(CRM)。它们适用于多种分析应用，包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。
奥氮平可用作药物参考标准品，用于使用高效液相色谱和分光光度法技术对药物制剂中的分析物进行定量。 分析说明 这些二级标准品可追溯至USP、EP和BP一级标准品。 其他说明 该认证参考物质(CRM)根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。 附注 要查看该材料的分析证书示例，请在下面的栏位中输入 LRAC0272。这只是一个示例证书，可能不是您收到的批次。 基本信息 | 经验(实验)分子式 | C17H20N4S | | 分子量 | 312.43 | | Beilstein | 7655141 | | MDL编号 | MFCD00866702 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material
pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | pkg of 1 g | | technique(s) | HPLC: suitable
gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 1060
traceable to PhEur Y0001370
traceable to USP 1478301 | | 储存温度 | 2-30℃ | | SMILES string | CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24 | | InChI | 1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 | | InChI key | KVWDHTXUZHCGIO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), DRD3(1814), DRD4(1815), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 |  | | 警示用语： | Warning | | 危险声明 | H315 - H319 | | 预防措施声明 | P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P337 + P313 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001370 | | Olanzapine | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C17H20N4S | | 分子量 | 312.43 | | Beilstein | 7655141 | | MDL编号 | MFCD00866702 | | PubChem化学物质编号 | 329831386 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24 | | InChI | 1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 | | InChI key | KVWDHTXUZHCGIO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), DRD3(1814), DRD4(1815), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H315 - H319 | | 预防措施声明 | P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001380 | | Olanzapine for system suitability | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C17H20N4S | | 分子量 | 312.43 | | Beilstein | 7655141 | | MDL编号 | MFCD00866702 | | PubChem化学物质编号 | 329831393 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24 | | InChI | 1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 | | InChI key | KVWDHTXUZHCGIO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), DRD3(1814), DRD4(1815), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H315 - H319 | | 预防措施声明 | P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1478301 | USP | Olanzapine | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C17H20N4S | | 分子量 | 312.43 | | Beilstein | 7655141 | | MDL编号 | MFCD00866702 | | PubChem化学物质编号 | 329750606 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24 | | InChI | 1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 | | InChI key | KVWDHTXUZHCGIO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), DRD3(1814), DRD4(1815), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H315 - H319 | | 预防措施声明 | P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P337 + P313 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1060 | | Olanzapine | British Pharmacopoeia (BP) Reference Standard | 2235.38元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C17H20N4S | | 分子量 | 312.43 | | Beilstein | 7655141 | | MDL编号 | MFCD00866702 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24 | | InChI | 1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 | | InChI key | KVWDHTXUZHCGIO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), DRD3(1814), DRD4(1815), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H315 - H319 | | 预防措施声明 | P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
m.cnreagent.com